排序方式: 共有25条查询结果,搜索用时 15 毫秒
21.
目的 探讨腹型过敏性紫癜的临床特点,提高对本病的认识和早期诊断水平.方法 回顾性分析6例腹型过敏性紫癜患者的临床资料.结果 6例患者均以消化道症状为首要表现就诊,伴恶心、呕吐3例,腹泻1例,呕血和便血1例.实验室检查发现白细胞计数升高3例,血尿淀粉酶升高1例,最初诊断急性胃肠炎3例,急性胰腺炎1例,消化道出血(可疑为出血性坏死性肠炎)1例,急性阑尾炎1例.入院后2~6 d出现皮肤紫癜而得到确诊,治疗后全部患者痊愈出院,无并发症.结论 腹型过敏性紫癜缺乏特异性临床表现,给正确的诊断带来困难,掌握本病的临床特点,提高对本病的认识有助于获得早期正确的诊断.
Abstract:
Objective To investigate the clinical features of patients with abdominal type Henoch-Schonlein putpura (HSP).Methods The clinical data of 6 cases of HSP with gastrointestinal involvement were retrospectively analyzed. Results All patients complained of abdominal pain and other clinical manifestations included nausea/vomiting(3 cases),diarrhea (1 case), alimentary tract hemorrhage (1 case), elevated WBC count in peripheral blood (1 case) and elevated blood/urine amylase (1 case).All cases received non-operative therapy and discharged from the hospital after their recovery. Conclusions The abdominal-type HSP patients have no typical clinical manifestation and usually were misdiagnosed, and more attention paid to this disease would conduce to the diagnosis in the early stage. 相似文献
22.
23.
24.
25.
目的探讨应用射频消融联合放射性粒子^125I治疗肝癌的疗效及可行性。方法采用射频消融联合放射性粒子^125I治疗肝癌12例,其中原发性肝癌9例,术后复发肝癌2例,复发肝癌伴淋巴结转移1例。在综合治疗指导下,利用射频消剐联合放射性粒子^125I进行治疗。结果12例;蕙者手术均顺利完成。所有患者术后均无出血、感染、胆漏等产重并发症,患者肝功能出现损害,经常规保肝治疗后恢复。于术后1、3、6个月复查CT查肿瘤体积缩小分别为(34.57±4.52)%、(47.12±4.71)%、(32.37±5.29)%。术后3个月全部存活,术后6个月存活9例,术后1年存活5例,3例患者存活已达14个月,余患者死于全身转移和肝功能衰竭。结论射频消融联合放射性粒子^125I治疗肝癌具有安全性、微创及并发症发生率低的特点,是综合治疗肝癌的有效手段之一。 相似文献